Table 2.
The atopy features and the frequency of allergic comorbidity of the study population
| ACO (n=40) (11.8%) | Asthma (n=298) (88.2%) | p | |
|---|---|---|---|
| Skin prick positive, n (%) | 4/16 (25%) | 75/189 (39.7%) | 0.3732 |
| Total IgE (IU/dL) | 33.3 (12–233) | 70 (6–2432) | 0.2461 |
| Blood eosinophils, n (min-max) | 100 (0–600) | 170 (0–1017) | 0.8301 |
| Blood eosinophils, % (min-max) | 1.42 (0–6.5) | 2.1 (0–15.5) | 0.5301 |
| Presence of any allergic comorbidity, n (%) | 17 (42.5%) | 194 (65.1%) | 0.0092 |
1
Kruskal-Wallis test
2
Continuity correction Chi-square test
ACO: asthma-COPD overlap